These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9819695)

  • 1. Treatment of superficial pseudomonal infections with citric acid: an effective and economical approach.
    Nagoba BS; Deshmukh SR; Wadher BJ; Mahabaleshwar L; Gandhi RC; Kulkarni PB; Mane VA; Deshmukh JS
    J Hosp Infect; 1998 Oct; 40(2):155-7. PubMed ID: 9819695
    [No Abstract]   [Full Text] [Related]  

  • 2. Citric acid treatment of severe electric burns complicated by multiple antibiotic resistant Pseudomonas aeruginosa.
    Nagoba BS; Gandhi RC; Wadher BJ; Deshmukh SR; Gandhi SP
    Burns; 1998 Aug; 24(5):481-3. PubMed ID: 9725693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future perspectives for levofloxacin in severe Pseudomonas aeruginosa infections.
    Marchetti F; Viale P
    J Chemother; 2003 Aug; 15(4):315-22. PubMed ID: 12962358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory investigations on ticarcillin, an anti-pseudomonal antibiotic.
    Wise R; Reeves DS
    Chemotherapy; 1974; 20(1):45-51. PubMed ID: 4210893
    [No Abstract]   [Full Text] [Related]  

  • 5. Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private, university-affiliated teaching hospital: an 8-year-experience: 1995-2002.
    Mohr JF; Jones A; Ostrosky-Zeichner L; Wanger A; Tillotson G
    Int J Antimicrob Agents; 2004 Oct; 24(4):346-51. PubMed ID: 15380259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effective agents against Pseudomonas pyocyanea (proceedings)].
    Meyer-Rohn J
    Z Hautkr; 1976; 51 Suppl 2():106-8. PubMed ID: 827860
    [No Abstract]   [Full Text] [Related]  

  • 7. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections.
    Driscoll JA; Brody SL; Kollef MH
    Drugs; 2007; 67(3):351-68. PubMed ID: 17335295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.
    Pritchard MF; Powell LC; Jack AA; Powell K; Beck K; Florance H; Forton J; Rye PD; Dessen A; Hill KE; Thomas DW
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility and serotyping of Pseudomonas aeruginosa strains isolated in Bogota, Columbia.
    Rodríguez B; Vásquez E; Sussmann O; Máttar S; Jaramillo CA
    Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):152-4. PubMed ID: 10746508
    [No Abstract]   [Full Text] [Related]  

  • 10. [In vitro sensitivity of 39 strains of Pseudomonas aeruginosa isolated from urine culture of hospitalized patients].
    Vanni M; Zucca C
    Minerva Med; 1986 Jun; 77(27):1289-92. PubMed ID: 3088493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic in vitro and in vivo activities of ampicillin and aminoglycoside combinations against antibiotic-resistant Pseudomonas aeruginosa strains.
    Elkhouly AE; el-Sokkary MA; el-Emam MA
    Chemioterapia; 1987 Jun; 6(2 Suppl):125-8. PubMed ID: 3151331
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of experimental rabbit infective endocarditis due to a multidrug-resistant Pseudomonas aeruginosa with high-dose ceftazidime alone and combined with amikacin or sulbactam or both.
    Xiong YQ; Caillon J; Zhou XY; Potel G; Bugnon D; Le Conte P; Le Gallou F; Le Floch R; Baron D; Drugeon H
    J Antimicrob Chemother; 1995 May; 35(5):697-706. PubMed ID: 7592185
    [No Abstract]   [Full Text] [Related]  

  • 13. A long-term study of gentamicin-resistant Pseudomonas aeruginosa in a general hospital.
    Duncan IB; Rennie RP; Duncan NH
    J Antimicrob Chemother; 1981 Feb; 7(2):147-55. PubMed ID: 6783608
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metallo-beta-lactamases producing Pseudomonas aeruginosa in Algeria].
    Aggoune-Khinache N; Bensersa D; Henniche FZ; Daoudi M; Abdouni MA; Chabani A; Tiouit D; Naim M
    Med Mal Infect; 2009 Jun; 39(6):413-4. PubMed ID: 19111417
    [No Abstract]   [Full Text] [Related]  

  • 15. Colistin: an antimicrobial for the 21st century?
    Stein A; Raoult D
    Clin Infect Dis; 2002 Oct; 35(7):901-2. PubMed ID: 12228836
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluoroquinolone use is not associated with the change in imipenem susceptibility of Pseudomonas aeruginosa in 25 hospitals.
    Eagye KJ; Nicolau DP
    Adv Ther; 2011 Apr; 28(4):326-33. PubMed ID: 21445549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of membrane permeability in determining antibiotic resistance in Pseudomonas aeruginosa.
    Nakae T
    Microbiol Immunol; 1995; 39(4):221-9. PubMed ID: 7544425
    [No Abstract]   [Full Text] [Related]  

  • 18. Antipseudomonal antibiotics.
    Giamarellou H; Antoniadou A
    Med Clin North Am; 2001 Jan; 85(1):19-42, v. PubMed ID: 11190351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serological typing of strains of Pseudomonas aeruginosa. II. Correlations between the O-serotype and sensitivity to 3 aminoglycosides (tobramycin, gentamicin and sisomicin)].
    Berti P; Maranini B; Mazzoni P
    Ann Sclavo; 1980; 22(4):709-16. PubMed ID: 6787999
    [No Abstract]   [Full Text] [Related]  

  • 20. [In-vitro antibiotic resistance of hospital and non-hospital strains of Pseudomonas aeruginosa].
    Ceddia T; Marinucci MC; Parravano N
    Boll Soc Ital Biol Sper; 1979 Mar; 55(6):529-33. PubMed ID: 121701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.